162 related articles for article (PubMed ID: 22068968)
1. Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice.
Kuo WL; Yu MC; Lee JF; Tsai CN; Chen TC; Chen MF
J Gastrointest Surg; 2012 Feb; 16(2):361-9. PubMed ID: 22068968
[TBL] [Abstract][Full Text] [Related]
2. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate.
Kim Y; Fiel MI; Albanis E; Chou HI; Zhang W; Khitrov G; Friedman SL
Liver Int; 2012 Jul; 32(6):1008-17. PubMed ID: 22507133
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.
Yoshiji H; Kuriyama S; Noguchi R; Ikenaka Y; Yoshii J; Yanase K; Namisaki T; Kitade M; Yamazaki M; Asada K; Akahane T; Tsujimoto T; Uemura M; Fukui H
Int J Mol Med; 2006 May; 17(5):899-904. PubMed ID: 16596278
[TBL] [Abstract][Full Text] [Related]
4. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis.
Zhang CG; Zhang B; Deng WS; Duan M; Chen W; Wu ZY
World J Gastroenterol; 2016 May; 22(18):4484-500. PubMed ID: 27182159
[TBL] [Abstract][Full Text] [Related]
5. Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases.
Shaker ME; Ghani A; Shiha GE; Ibrahim TM; Mehal WZ
Biochim Biophys Acta; 2013 Aug; 1833(8):1992-2003. PubMed ID: 23499874
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis.
Yu FX; Teng YY; Zhu QD; Zhang QY; Tang YH
Biochem Cell Biol; 2014 Oct; 92(5):406-12. PubMed ID: 25289759
[TBL] [Abstract][Full Text] [Related]
7. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea attenuates hepatic stellate cell proliferation in vitro and liver fibrogenesis in vivo.
Haijer F; Koets-Shajari S; Heegsma J; Serna-Salas S; Blokzijl T; Buist-Homan M; Moshage H; Faber KN
FASEB J; 2023 Sep; 37(9):e23124. PubMed ID: 37552464
[TBL] [Abstract][Full Text] [Related]
9. NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats.
Lin N; Chen S; Pan W; Xu L; Hu K; Xu R
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C469-77. PubMed ID: 21543745
[TBL] [Abstract][Full Text] [Related]
10. Gant61 ameliorates CCl
Jiayuan S; Junyan Y; Xiangzhen W; Zuping L; Jian N; Baowei H; Lifang J
Toxicol Appl Pharmacol; 2020 Jan; 387():114853. PubMed ID: 31816328
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice.
Wu Y; Li Z; Xiu AY; Meng DX; Wang SN; Zhang CQ
Drug Des Devel Ther; 2019; 13():2667-2676. PubMed ID: 31534314
[TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.
Yoshiji H; Noguchi R; Kuriyama S; Ikenaka Y; Yoshii J; Yanase K; Namisaki T; Kitade M; Masaki T; Fukui H
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G907-13. PubMed ID: 15618280
[TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
14. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
15. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI
PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318
[TBL] [Abstract][Full Text] [Related]
16. Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term.
Neef M; Ledermann M; Saegesser H; Schneider V; Widmer N; Decosterd LA; Rochat B; Reichen J
J Hepatol; 2006 Jan; 44(1):167-75. PubMed ID: 16168515
[TBL] [Abstract][Full Text] [Related]
17. EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells.
Mimche PN; Lee CM; Mimche SM; Thapa M; Grakoui A; Henkemeyer M; Lamb TJ
Sci Rep; 2018 Feb; 8(1):2532. PubMed ID: 29416088
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors.
Sharma A; Verma AK; Kofron M; Kudira R; Miethke A; Wu T; Wang J; Gandhi CR
Hepatology; 2020 Nov; 72(5):1800-1818. PubMed ID: 32064648
[TBL] [Abstract][Full Text] [Related]
19. The combined induction of liver progenitor cells and the suppression of stellate cells by small molecules reverts chronic hepatic dysfunction.
Huang WJ; Zhou X; Fu GB; Ding M; Wu HP; Zeng M; Zhang HD; Xu LY; Gao Y; Wang HY; Yan HX
Theranostics; 2021; 11(11):5539-5552. PubMed ID: 33859762
[No Abstract] [Full Text] [Related]
20. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.
Sanz S; Pucilowska JB; Liu S; Rodríguez-Ortigosa CM; Lund PK; Brenner DA; Fuller CR; Simmons JG; Pardo A; Martínez-Chantar ML; Fagin JA; Prieto J
Gut; 2005 Jan; 54(1):134-41. PubMed ID: 15591519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
